Stay updated on Dolutegravir for HIV Treatment Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.

Latest updates to the Dolutegravir for HIV Treatment Clinical Trial page
- Check4 days agoChange DetectedA notice about NIH’s terminology transition was added above the 403 error page, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now shows a 403 Forbidden error, including the HTML snippet for the 403 page and a Home link, indicating access is blocked and the underlying study details are not visible.SummaryDifference16%

- Check39 days agoChange DetectedThe page now displays the revision label v3.7.0, replacing the previous v3.6.6. This metadata update signals a new page version without changing the study details.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page footer revision tag was updated from v3.6.5 to v3.6.6, indicating a new page revision.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page’s revision has been updated from v3.6.4 to v3.6.5, indicating a minor update to the page template or rendering. No changes to study details, eligibility criteria, locations, or other user-facing content.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir for HIV Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.